Abstract
The organometallic glutathione S-transferase inhibitor ruthenium(II) (ethacrynic acid-η6-benzylamide)(1,3,5-triaza-7-phosphaadamantane) dichloride, termed ethaRAPTA, has been demonstrated to induce apoptosis in the cisplatin-resistant MCF-7 breast cancer cell line. Probing the molecular basis of this activity suggests that the complex triggers multiple pathways toward apoptosis, including those involving endonuclease G, caspases, and c-Jun N-terminal kinase, which could provide a therapy for multi-drug-resistant tumors. Furthermore, the induction of heat shock protein 70 expression enhances selectivity of the complex for tumor cells, reducing the general toxicity.
Similar content being viewed by others
References
Rosenberg B, VanCamp L, Trosko JE, Mansour VH (1969) Nature 222:385–386
Kelland L (2007) Nat Rev Cancer 7:573–584
Rabik CA, Dolan ME (2007) Cancer Treat Rev 33:9–23
Strohfeldt K, Tacke M (2008) Chem Soc Rev 37:1174–1187
Rudnev AV, Foteeva LS, Kowol C, Berger R, Jakupec MA, Arion VB, Timerbaev AR, Keppler BK (2006) J Inorg Biochem 100:1819–1826
Sava G, Zorzet V, Turrin C, Vita F, Soranzo MR, Zabucchi G, Cocchietto M, Bergamo A, DiGiovine S, Pezzoni G, Sartor L, Garbisa S (2003) Clin Cancer Res 9:1898–1905
Hartinger CG, Zorbas-Seifried S, Jakupec MA, Kynast B, Zorbas H, Keppler BK (2006) J Inorg Biochem 100:891–904
Hartinger CG, Jakupec MA, Zorbas-Seifried S, Groessl M, Egger A, Berger W, Zorbas H, Dyson PJ, Keppler BK (2008) Chem Biodivers 5(10):2140–2155
Jänicke RU (2008) Breast Cancer Res Treat 117:219–221
Porter AG, Jänicke RU (1999) Cell Death Differ 6:99–104
Hanson CJ, Bootman MD, Roderick HL (2004) Curr Biol 14:R933–R935
Dyson PJ, Sava G (2006) Dalton Trans (16):1929–1933
Rademaker-Lakhai JM, van den Bongard D, Pluim D, Beijnen JH, Schellens JH (2004) Clin Cancer Res 10:3717–3727
Schluga P, Hartinger CG, Egger A, Reisner E, Galanski M, Jakupec MA, Keppler BK (2006) Dalton Trans (14):1796–1802
Jakupec MA, Reisner E, Eichinger A, Pongratz M, Arion VB, Galanski M, Hartinger CG, Keppler BK (2005) J Med Chem 48:2831–2837
Clarke MJ (2003) Coord Chem Rev 236:209–232
Sulyok M, Hann S, Hartinger CG, Keppler BK, Stingeder G, Koellensperger G (2005) J Anal At Spectrom 20:856–863
Ang WH, Dyson PJ (2006) Eur J Inorg Chem 20:4003–4018
Timerbaev AR, Hartinger CG, Aleksenko SS, Keppler BK (2006) Chem Rev 106:2224–2248
Hartinger CG, Zorbas-Seifried S, Jakupec MA, Kynast B, Zorbas H, Keppler BK (2006) J Inorg Biochem 100:891–904
Rademaker-Lakhai Jm, van den Bongard D, Pluim D, Beijnen JH, Schellens JH (2004) Clin Cancer Res 10:3717–3727
Dyson PJ (2007) Chimia 61:698–703
Dyson PJ, Hartinger CG (2009) Chem Soc Rev 38:391–401
Süss-Fink G (2010) Dalton Trans 39:1673–1688
Scolaro C, Bergamo A, Brescacin L, Delfino R, Cocchietto M, Laurenczy G, Geldbach TJ, Sava G, Dyson PJ (2005) J Med Chem 48:4161–4171
Bergamo A, Masi A, Dyson PJ, Sava G (2008) Int J Oncol 33:1281–1289
Chatterjee S, Kundu S, Bhattacharyya A, Hartinger CG, Dyson PJ (2008) J Biol Inorg Chem 13:1149–1155
Ang WH, de Luca A, Chapuis-Bernasconi C, Juillerat-Jeanneret L, Lo Bello M, Dyson PJ (2007) Chem Med Chem 2:1799–1806
Ang WH, Parker LJ, de Luca A, Juillerat-Jeanneret L, Morton CJ, Lo Bello M, Parker MW, Dyson PJ (2009) Angew Chem Int Ed 48:3854–3857
Fuertes MA, Perez JM, Alonso C (2003) Chem Rev 103:645–662
Niitsu Y, Takahashi Y, Ban N, Takayama T, Saito T, Katahira T, Umetsu Y, Nakajima T, Ohi M, Kuga T, Sakamaki S, Matsunaga T, Hirayama Y, Kuroda H, Homma H, Kato J, Kogawa K (1998) Chem Biol Interact 112:325–332
Goto S, Iida T, Cho S, Oka M, Kohno S, Kondo T (1999) Free Radic Res 31:549–558
Oude Elferink RP, Bakker CT, Jansen PL (1999) Toxicol Appl Pharmacol 157:85–93
Wang T, Arifoglu P, Ronai Z, Tew KD (2001) J Biol Chem 276:20999–21003
Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z (1999) EMBO J 18:1321–1334
Huang J, Tan PH, Tan KH, Bay BH (2004) Oncol Rep 12:921–925
Ang WH (2007) Novel strategies for overcoming drug resistance in transition metal-based anticancer compounds. PhD thesis, EPFL
Sheehan D, Meade G (2000) Biochem Soc Trans 28:27–32
Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, Knox SJ (2002) Cell Death Diff 9:252–263
Allardyce CS, Dyson PJ, Ellis DJ, Heath SL (2001) Chem Commun 1396–1397
Gaiddon C, Jeannequin P, Bischoff P, Pfeffer M, Sirlin C, Loeffler JP (2005) J Pharmacol Exp Ther 315:1403–1411
van Rijt SH, Sadler PJ (2009) Drug Discov Today 14:1089–1097
Schmid WF, John RO, Muehlgassner G, Heffeter P, Jakupec MA, Galanski M, Berger W, Arion VB, Keppler BK (2007) J Med Chem 50:6343–6355
Debreczeni JE, Bullock AN, Atilla GE, Williams DS, Bregman H, S. Knapp S, Meggers E (2006) Angew Chem 45:1580–1585
Mattsson J, Govindaswamy P, Renfrew AK, Dyson PJ, Štěpnička P, Süss-Fink G, Therrien B (2009) Organometallics 28:4350–4357
Kandioller W, Hartinger CG, Nazarov AA, Kuznetsov ML, John RO, Bartel C, Jakupec MA, Arion VB, Keppler BK (2009) Organometallics 28:4249–4251
Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pincus MR, Sardana M, Henderson CJ, Wolf CR, Davis RJ, Ronai Z (1999) EMBO J 18:1321–1334
Wang R, Li C, Song D, Zhao G, Zhao L, Jing Y (2007) Cancer Res 67:7856–7864
Hayes JD, Pulford DJ (1995) Crit Rev Biochem Mol Biol 30:445–600
Bernardini S, Bernassola F, Cortese C, Ballerini S, Melino G, Motti C, Bellincampi L, Iori R, Federici G (2000) J Cell Biochem 77:645–653
Braun RJ, Zischka H, Madeo F, Eisenberg T, Wissing S, Büttner S, Engelhardt SM, Büringer D, Ueffing M (2006) J Biol Chem 281:25757–25767
Dupont-Versteegden EE, Strotman BA, Gurley CM, Gaddy D, Knox M, Fluckey JD, Peterson CA (2006) Am J Physiol Regul Integr Comp Physiol 291:R1730–R1740
Delimitreva SM, Zhivkova RS, Vatev IT, Toncheva DI (2005) Int J Dev Biol 49:409–416
Kuwahara D, Tsutsumi K, Kobayashi T, Hasunuma T, Nishioka K (2000) Cancer Lett 148:65–71
Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV (2006) Cell Death Differ 13:1434–1441
Acknowledgments
The authors express their sincere gratitude to the Department of Science and Technology, India. The Indo Swiss Bilateral Research Initiative (EPFL) is also gratefully acknowledged for funding this research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chatterjee, S., Biondi, I., Dyson, P.J. et al. A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosis. J Biol Inorg Chem 16, 715–724 (2011). https://doi.org/10.1007/s00775-011-0772-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-011-0772-0